Omnicell (OMCL) Reports In-Line Q4 EPS

Omnicell (NASDAQ: OMCL) reported Q4 EPS of $0.92, in-line with the analyst estimate of $0.92. Revenue for the quarter came in at $311.7 million versus the consensus estimate of $311.07 million.

GUIDANCE:

Omnicell sees Q1 2022 EPS of $0.65-$0.72, versus the consensus of $0.86. Omnicell sees Q1 2022 revenue of $312-318 million, versus the consensus of $301.38 million.

Omnicell sees FY2022 EPS of $3.75-$3.95, versus the consensus of $4.01. Omnicell sees FY2022 revenue of $1.37-1.43 billion, versus the consensus of $1.3 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M